Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
about
Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infectionsPhase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update.Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria.In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595.Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
P2860
Q28069563-308A458A-A0F5-4EA2-A793-A5B144EEECDEQ37287753-EC8041AE-C33D-4C24-9F54-B71332593FD4Q38679493-33D1EAE6-DAB2-44A7-B0B9-C2E23E696A52Q38853784-607D38E3-7A54-43C0-AD46-5D7E8F8C6538Q38981397-31277BA6-F6DB-417D-A803-7F4E24870D77Q40371584-D3222053-BB63-4E33-B8E0-5A5B085035F2Q40550507-7E4F356A-6BE5-4369-9C50-4C126D64EC80Q46267269-6347AE92-2E98-40ED-9604-B38E1AFD0CCAQ48713306-78BF9A97-9DB3-4F3B-B6AD-AEE49221EFD4Q53699378-1AAF4254-B716-4215-8B6B-046B6F47F29DQ57211457-A1D86174-9701-4C66-811C-EC8FC672D019
P2860
Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Activity of Ceftazidime-Avibac ...... lance Study from 2012 to 2014.
@en
type
label
Activity of Ceftazidime-Avibac ...... lance Study from 2012 to 2014.
@en
prefLabel
Activity of Ceftazidime-Avibac ...... lance Study from 2012 to 2014.
@en
P2093
P2860
P356
P1476
Activity of Ceftazidime-Avibac ...... lance Study from 2012 to 2014.
@en
P2093
Daniel F Sahm
Douglas J Biedenbach
Gregory G Stone
James A Karlowsky
Krystyna M Kazmierczak
P2860
P304
P356
10.1128/AAC.02286-15
P407
P577
2016-02-29T00:00:00Z